Marie José Kersten, Joost Vermaat, Pim Mutsaers, Maria Kuipers, Evelyne Willems, Sébastien Anguille, Tim Dekker, Caron Jacobson, Michael Bishop, Peter Vandenberghe, Guillaume Dachy, Andreas Klein, Jon Arnason, Stavros Milatos, Chiara Lobetti-Bodoni, Eva Santermans, Sandra Blum, Kirsten Van Hoorde, Maike Spoon, Omotayo Fasan, Martin Dreyling. "High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 MCL cohort." Blood (2025). https://doi.org/10.1182/blood-2025-662